Sargramostim Use in COVID-19 to Recover Patient Health

PHASE2CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

December 28, 2021

Study Completion Date

January 31, 2022

Conditions
Covid19SARS-CoV Infection
Interventions
DRUG

Sargramostim

All patients randomized to the sargramostim treatment arm will be treated with 250 mcg inhaled sargramostim administered via a vibrating mesh nebulizer once daily for 5 days.

DRUG

Placebo

All patients in the control arm will receive an equivalent volume of inhaled placebo diluent administered via a vibrating mesh nebulizer once daily for 5 days.

Trial Locations (37)

2000

Instituto Medico de la Fundacion Estudios Clinicos, Rosario

7600

Centro de Investigaciones Medicas Mar del Plata, Mar del Plata

10310

Richmond University Medical Center, Staten Island

15801

TruCare Internal Medicine and Infectious Disease, DuBois

21801

TidalHealth Peninsula Regional, Inc., Salisbury

28112

Monroe Biomedical Research, Monroe

29640

Urgent Care Clinical Trials @ AFC Urgent Care - Easley, Easley

30349

Paramount Research Solutions, College Park

30519

Gwinnett Research Institute, LLC, Buford

33012

Indago Research & Health Center, Inc. (Subject Visits Only), Hialeah

33021

Encore Medical Research, Hollywood

33157

IMIC Inc., Palmetto Bay

33308

Invesclinic US, LLC., Fort Lauderdale

33331

Encore Medical Research of Weston, Weston

34208

Synergy Healthcare, Bradenton

37411

University Diabetes & Endocrine Consultants, Chattanooga

38654

Olive Branch Family Medical Center, Olive Branch

43214

Hometown Urgent Care and Research, Columbus

45215

Hometown Urgent Care and Research, Cincinnati

45424

Urgent Care Specialists, LLC DBA Hometown Urgent Care and Research, Dayton

48312

Revival Research Institute, LLC., Sterling Heights

48334

Revive Research Institute, Inc., Farmington Hills

69101

Great Plains Health, North Platte

72212

Applied Research Center of Arkansas, Little Rock

75149

SMS Clinical Research, LLC, Mesquite

75204

UCCT @ City Doc Urgent Care-McKinney, Dallas

77030

Dorrington Medical Associates, Houston

77065

Encore Imaging & Medical Research, Houston

77584

Novotrial Research Group, Pearland

78215

Sun Research Institute, San Antonio

78539

Invesclinic US LLC, Edinburg

84108

University of Utah Health, Salt Lake City

85031

West Valley Research Clinic, LLC, Phoenix

89109

Excel Clinical Research, Las Vegas

91303

Hope Clinical Research, Canoga Park

92324

Benchmark Research, Colton

C1414DTK

Sanatorio Santa Barbara, Buenos Aires

Sponsors
All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Partner Therapeutics, Inc.

INDUSTRY